🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to evaluate the safety of rFVIIIFc (...
Status
Completed
Location
Research Site
Start Date
2015-01-12
Trial ID
NCT02234323
Treatments Being Tested
To investigate intervention with early application of non-ablative laser to...
Status
Completed
Location
Bispebjerg Hospital
Start Date
2015-09
Trial ID
NCT02645773
Treatments Being Tested
In patients with recurrent or metastatic renal cell carcinoma, a preliminar...
Status
Unknown
Location
Tianjin Medical Unversity Second Hospital
Start Date
2021-08-01
Trial ID
NCT04958473
Treatments Being Tested
Background Glaucoma is a progressive optic neuropathy characterized by ele...
Status
Recruiting
Location
Shafer Vision Institute
Start Date
2002-03-11
Trial ID
NCT07076303
Treatments Being Tested
This is a 12-month, parallel treatment, Phase 3, double-blind, randomized, ...
Status
Active Not Recruiting
Location
Nephrology Clinic at Kirklin Clinic of UAB Hospital_Investigational Site Number: 8400011
Start Date
2022-03-11
Trial ID
NCT05206773
Treatments Being Tested
This study is researching an experimental drug called odronextamab, referre...
Status
Recruiting
Location
Mayo Clinic - Arizona
Start Date
2023-12-13
Trial ID
NCT06091865
Treatments Being Tested
Evaluate the efficacy and safety of Anlotinib plus Pemetrexed as the 1-line...
Status
Unknown
Location
Beijing Chest Hospital
Start Date
2018-11-26
Trial ID
NCT03768037
Treatments Being Tested
Objectives: This study evaluates the efficacy of two mobile phone applicati...
Status
Completed
Location
Karolinska institutet, Department of Clinical Neuroscience
Start Date
2013-02
Trial ID
NCT01958398
Treatments Being Tested
This Phase III, randomized, double-blind, placebo-controlled study will com...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-11-16
Trial ID
NCT03274492
Phase 1B: Open label (all patients receive PEGPH20+gemcitabine), dose escal...
Status
Completed
Location
Highlands Oncology Group
Start Date
2011-09
Trial ID
NCT01453153
Treatments Being Tested